Analysts cut earnings per share estimates for Bank of N.T. Butterfield & Son, indicating potential business challenges. The bank's revenues are projected to underperform the broader industry. The consensus price target remains at US$35.20.
Bank of N.T. Butterfield & Son's moderate payout ratio and substantial EPS growth are favorable for its dividend payments. Considering these promising aspects, the firm could be drawing more attention from dividend-focused investors.
毕达菲尔特银行股票讨论
加载中...
加载中...
新增数据:23Q4,营收萎缩2.4%,主要是净利息收入减少造成的,叠加非利息费用增长,税前利润萎缩了17.4%,税后萎缩15.2%。
2023年营收增长5.33%,净利润增长5.4%。
负债表显示近两年客户存款一直在下降,从2021年的138.7亿下降近20亿到119.87亿,这不是好迹象,而资产端基本都是长期贷款和投资,现金和短期投资只有47亿,流动性不好,容易出挤兑问题。
目前市盈率6.55,股息率5.9%,估值还不算高,继续观察。
对收益/指导的回应:
$Liberty Energy (LBRT.US)$ +11.6%, $F5 Inc (FFIV.US)$ +6.9%, $Encore缆线 (WIRE.US)$ + 5.6%, $Archer Daniels Midland (ADM.US)$ +5.5%, $毕达菲尔特银行 (NTB.US)$ +5%, $奥尔巴尼国际 (AIN.US)$ +5%, $3M (MMM.US)$ +4.0%,
其他新闻:
$Shell Midstream (SHLX.US)$ +10%(美国壳牌将以15.85美元/单位总价值19.6亿美元的价格收购公众持有的SHLX的所有单位)
$BridgeBio Pharma (BBIO.US)$...
暂无评论